Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.19.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development $ 18,588 $ 9,477
General and administrative 5,663 3,373
Total operating expenses 24,251 12,850
Loss from operations (24,251) (12,850)
Other income (expense):    
Interest income 1,176 708
Interest expense   (208)
Other expense, net   (4,655)
Total other income (expense) 1,176 (4,155)
Net loss (23,075) (17,005)
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable securities 103 (88)
Total other comprehensive income (loss) 103 (88)
Comprehensive loss $ (22,972) $ (17,093)
Basic net loss per common share $ (0.37) $ (0.32)
Diluted net loss per common share $ (0.37) $ (0.32)
Weighted average common shares outstanding used to calculate basic net loss per common share 61,890,632 53,752,753
Weighted average common shares outstanding used to calculate diluted net loss per common share 61,890,632 53,752,753